NASDAQ: ACER Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Acer Therapeutics Inc.
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Acer Therapeutics Inc.
View full press release